pharma · Non-muscle Invasive Bladder Cancer · Non-Muscle Invasive Bladder Cancer
ImmunityBio
Immunitybio Ireland Limited
ImmunityBio trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
San Diego, USA HQ
2014 Founded
625 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2014
- Employees
- 625
- Programs
- 2
- Drugs
- 5
- Patents
- 0
ImmunityBio clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to ImmunityBio programs — each row shows trial ID, program name, phase, status, and indication.
ImmunityBio trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ImmunityBio.
Trial registry
-
CTIS ↗ - NCT02138734CT.gov ↗
BCG (50mg/instillation) + N-803 (400 μg/instillation)
Non-muscle Invasive Bladder Cancer